Company: INDP
Filing Date: 2025-02-12
Form Type: S-1
Source: 0001493152-25-006068
Chunk: 161

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-02-12
Form: S-1
Chunk 161
---
 the value of the options granted during the years ended December 31, 2023 and 2022 are presented in the table below. The weighted average fair value of stock options issued during the years ended December 31, 2023 and 2022 was $ 1.43and $ 3.27per share, respectively.

SCHEDULE OF WEIGHTED AVERAGE INPUTS USED TO MEASURE VALUE OF OPTIONS GRANTED

|                          |     |   |  2023 |   |     |   |  2022 |   |
|:-------------------------|:----|:--|------:|:--|:----|:--|------:|:--|
| Exercise price           |     | $ |  1.70 |   |     | $ |  4.04 |   |
| Expected term (in years) |     |   |   5.8 |   |     |   |   5.8 |   |
| Volatility               |     |   | 110.9 | % |     |   | 106.6 | % |
| Risk free rate           |     |   |   3.7 | % |     |   |   2.2 | % |
| Dividend yield           |     |   |   0.0 | % |     |   |   0.0 | % |

| F-12 |

The following table presents the exercise price of outstanding stock options as of December 31, 2023:

SCHEDULE OF EXERCISE PRICE OF OUTSTANDING STOCK OPTIONS

| Exercise price   |     | Options     
 outstanding |           |
| $0.01 - $8.00    |     |             | 1,023,249 |
| $0.01 - $8.00    |     |             | 1,023,249 |
| $8.01 - $16.00   |     |             |   992,250 |
| $16.01 or higher |     |             |    34,698 |
| Total            |     |             | 2,050,197 |

NOTE 7: CAPITALIZATION

| a. | As                                                                                                                                       
 of December 31, 2023 and December 31, 2022, the Company had 200,000,000 shares of common stock authorized and 8,401,047 shares of common 
 stock issued and outstanding. As of December 31,